Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Wegovy (semaglutide) Approved - An injectable GLP-1 receptor agonist approved for chronic weight management
A 52-week study found that the most common side effects were: nausea (experienced by 40% of participants) flushing (20%) headache (12%) You also might notice that your blood pressure goes up and your heart rate goes down each time you take it
The problem is not always that GLP-1 made you tired
Choose cagrilintide if You want a compound with a milder side effect profile
US$ 22.86
US$ 28.38
US$ 25.44
US$ 22.48
